H.R. 3537 · 117th Congress

Accelerating Access to Critical Therapies for ALS Act

Stage
Signed by the president
Sponsor
Mike Quigley
Introduced
2021-05-25
Latest action
2021-12-23 · Presented to President.

Action history

  1. 2021-12-23Presented to President.
  2. 2021-12-23Signed by President.
  3. 2021-12-23Became Public Law No: 117-79.
  4. 2021-12-17Message on Senate action sent to the House.
  5. 2021-12-16Passed Senate without amendment by Voice Vote.
  6. 2021-12-09Motion to reconsider laid on the table Agreed to without objection.
  7. 2021-12-09On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 415).
  8. 2021-12-09Considered as unfinished business.
  9. 2021-12-09Received in the Senate, read twice.
  10. 2021-12-08At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  11. 2021-12-08DEBATE - The House proceeded with forty minutes of debate on H.R. 3537.
  12. 2021-12-08Considered under suspension of the rules.
  13. 2021-12-08Mr. Pallone moved to suspend the rules and pass the bill, as amended.
  14. 2021-12-08Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 117-207.
  15. 2021-12-08Placed on the Union Calendar, Calendar No. 148.
  16. 2021-11-17Committee Consideration and Mark-up Session Held.
  17. 2021-11-17Ordered to be Reported (Amended) by Voice Vote.
  18. 2021-11-04Subcommittee Consideration and Mark-up Session Held.
  19. 2021-11-04Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
  20. 2021-05-26Referred to the Subcommittee on Health.
  21. 2021-05-25Introduced in House
  22. 2021-05-25Referred to the House Committee on Energy and Commerce.